|
Match
|
Document |
Document Title |
|
|
7569232 |
Medium chain peroxycarboxylic acid compositions
The present invention relates to compositions including medium chain peroxycarboxylic acid, methods for making these compositions, and methods for reducing the population of a microorganism. The...
|
|
|
7566442 |
Integrin targeted imaging agents
Emulsions preferably of nanoparticles formed from high boiling liquid perfluorochemical substances, said particles coated with a lipid/surfactant coating are made specific to regions of activated...
|
|
|
7553844 |
Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors
The present invention relates to a drug combination capable of conferring therapeutic benefits in the treatment of both AIDS and malaria. In particular, it relates to a drug combination including...
|
|
|
RE40812 |
Nasal calcitonin formulation
A liquid pharmaceutical composition is disclosed comprising calcitonin or an acid addition salt thereof and citric acid or salt thereof in a concentration from about to about 50 mM, said...
|
|
|
RE40786 |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
This invention relates to parenteral and mucosal vaccines against diseases caused by intercellular pathogens using antigens encapsulated within a biodegradable-biocompatible microspheres(matrix).
|
|
|
7541347 |
Minocycline oral dosage forms for the treatment of acne
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
|
|
|
7498309 |
Pharmaceutical compositions for bioactive peptide agents
Disclosed are pharmaceutical compositions suitable for oral administration of bioactive peptides. Particularly, the pharmaceutical compositions comprise peptides formulated as suspensions...
|
|
|
7452552 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Pharmaceutical compositions for lipophilic drugs
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in...
|
|
|
7416869 |
Enzyme delivery systems, application in water based products
Aqueous enzyme delivery systems as well as aqueous cosmetics and personal care products were provided which comprise at least one stabile enzyme and a polyglycerol containing at least 15 carbons....
|
|
|
7387790 |
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
Nanoparticles made from a select group of lipids and optionally containing a therapeutically active agent are employed in pharmaceutical compositions for delivery to targeted tissues and/or cells...
|
|
|
7374779 |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
The present invention pertains to pharmaceutical formulations and systems for delivery of active agents, wherein a first fraction of an active agent is suspended in a vehicle and a second fraction...
|
|
|
7368120 |
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance...
|
|
|
7364752 |
Solid dispersion pharamaceutical formulations
A pharmaceutical composition is disclosed which comprises a solid dispersion of an HIV protease inhibitor in a water soluble carrier, such as PEG, having enhanced bioavailability and improved...
|
|
|
7285290 |
Hydrophilized powder and a composition comprising the same
The present invention is hydrophilized powder, wherein the powder is surface treated with polyether-modified silicone having a hydrolyzable silyl group according to the formula (1),
...
|
|
|
7273622 |
Super absorption Coenzyme Q10
An improved soft gelatin formulation and process methodology that increases single Coenzyme Q 10 molecules presented to the absorption channels of the small intestines by providing medium chain...
|
|
|
7273606 |
Solubilized CoQ-10 and carnitine
The present invention is directed to compositions and methods of delivery of CoQ-10 and an amino acid solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the...
|
|
|
7264824 |
Oral dosage form
Oral dosage form for food and food supplement as well as dietetics comprising polyunsaturated acids in a xylose-hardened gelatine capsule with a retarded release time.
|
|
|
7229639 |
Ibuprofen containing hard shell capsules
The present invention relates to pharmaceutically acceptable and stable compositions, which are preferably clear transparent, for liquid filling hard shell capsules, hard shell capsules containing...
|
|
|
7226932 |
Self-emulsifying drug delivery system
Oral pharmaceutical formulation which improves the bioavailability of pharmaceuticals which are substantially water and oil insoluble is disclosed. In addition to the pharmaceutical, the...
|
|
|
7205279 |
Pharmaceutical compositions
This invention provides a microemulsion pre-concentrate comprising a difficultly soluble active agent and a carrier medium comprising 1) a hydrophilic phase which comprises dimethylisosorbide...
|
|
|
7201921 |
Antihistamine formulations for soft capsule dosage forms
The invention herein relates to a pharmaceutical composition containing loratadine and derivatives thereof which is suitable for use in soft capsule dosage forms. A pharmaceutical composition...
|
|
|
7198795 |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
Disclosed are in vitro methods for evaluating the in vivo redispersibility of dosage forms of poorly water-soluble active agents. The methods utilize media representative of in vivo human...
|
|
|
7189415 |
Rapidly disintegrable pharmaceutical composition
The present invention relates to a pharmaceutical composition useful for rapid disintegration, which comprises a sparingly soluble medicament held on a gel-forming water-soluble polymer as a solid...
|
|
|
7186415 |
Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type, containing boron nitride
Cosmetic or dermatological preparations, which are finely dispersed systems of the oil-in-water or water-in-oil type, comprising
1. an oil phase, 2. an aqueous phase, 3. boron nitride which...
|
|
|
7182958 |
β-carboline pharmaceutical compositions
Formulations containing a PDE5 inhibitor, a water-soluble diluent, a lubricant, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use...
|
|
|
7166300 |
Agent for inducing hair growth containing extracts of saw palmetto and swertia
The present invention consists in a composition comprising a mixture of extracts of saw palmetto and swertia , of derivatives thereof and of active components being part of said extracts. The...
|
|
|
7166299 |
Preparation of aqueous clear solution dosage forms with bile acids
Compositions for pharmaceutical and other uses comprising clear aqueous solutions of bile acids which do not form any detectable precipitates over selected ranges of pH values of the aqueous...
|
|
|
7166295 |
Methods of treatment and diagnostic visualization, particularly in cancer
Methods and reagents for improved treatment and diagnostic imaging, particularly of cancer. The methods and reagents utilize specific targeting of treatment and imaging ligands to the targeted...
|
|
|
7147867 |
Dosage form comprising liquid formulation
A dosage form is disclosed comprising a drug formulation that self-emulsifies in the drug formulation.
|
|
|
7144585 |
Cilostazol preparation
Provided is a cilostazol preparation which comprises incorporating a fine powder of cilostazol into a dispersing and/or solubilizing agent thereby to enhance the dispersibility and/or solubility....
|
|
|
7128933 |
Composition and method for the treatment of personal odors
An orally ingestible composition for the treatment of external personal odors can include about 35% w/w to about 50% w/w of the essential oil of lavender, about 1% w/w to about 10% w/w of the...
|
|
|
7115277 |
Method for enabling delivery of an active agent
A method for enabling deliver of an active agent is provided which includes the preparation of doses of the active agent distributing educational materials and guidelines for counseling patients...
|
|
|
7097852 |
Solution comprising sea water as expectorant and virucidal for the treatment of respiratory diseases and method to use and develop
A solution comprised filtered natural sea water comprising pharmaceutically active salts and trace elements having a direct effect in the respiratory tissues and secretions as expectorant,...
|
|
|
7087245 |
ICAM-1 formulation having controlled-size microparticles
Method and system of producing microparticles loaded with biologically active drugs, including proteins such as ICAM-1, for controlled release of the drugs in a nasal passageway. The method...
|
|
|
7087215 |
Methods of administering and enhancing absorption of pharmaceutical agents
Pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form are disclosed. The mixed micelles are formed from an alkali metal alkyl sulfate, and at least...
|
|
|
7081253 |
Use of nanodispersions in pharmaceutical end formulations
A description is given of the use of a nanodispersion, which comprises
(a) a membrane-forming molecule, (b) a coemulsifier and (c) a lipophilic component, in pharmaceutical end formulations,...
|
|
|
7078054 |
Soft gelatin capsule manufacture
Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a...
|
|
|
7070802 |
Pharmaceutical compositions for lipophilic drugs
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in...
|
|
|
7067153 |
Microcapsule powder
A process for making hydrophobicized powders of micro- and/or nanocapsules involving the steps of: (a) providing an aqueous polymer solution containing at least one active ingredient and at least...
|
|
|
7056539 |
Process and product extracted from herbal composition useful in controlling diabetes mellitus type II
An active substance is extracted from an herbal composition which comprises: Centaurii umbellatum, Gentianaceae (centaury plant), Teraxacum officinale, Asteraceae (dandelion root), Juniperi...
|
|
|
7056530 |
Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
A selfemulsifiable formulation comprising a lipophilic system consisting of a medium chain triglyceride of caprylic acid and capric acid, and of labrasol, wherein labrasol also serves as a...
|
|
|
RE39104 |
Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
A process for the production of a solid dispersion of at least one therapeutic agent in a hydrophilic carrier having enhanced solubility in an aqueous media comprising dissolving at least one...
|
|
|
7045146 |
Templating of solid particles by polymer multilayers
Process for encapsulation of an uncharged crystalline solid particle include treating the crystalline solid particle material with amphiphilic substances and subsequently coating the material with...
|
|
|
7022509 |
Gas vesicles of cells and methods of harvesting, isolating and modifying same
A method for removing a gas from a site comprising placing cells having gas vesicles under conditions that induce the cells to float to a surface of an aqueous medium, harvesting the cells from the...
|
|
|
7019106 |
Lactic acid polymer and process for producing the same
A process for producing a lactic acid polymer of 15,000 to 50,000 in weight-average molecular weight, the content of polymeric materials having not more than about 5,000 in weight-average molecular...
|
|
|
7015245 |
Formulation to enhance antioxidant potency of Vitamin E
A formulation to deliver a full-spectrum of Vitamin E isomers for improved antioxidant capacity, bioavailability, dissolution and efficacy. The formulation includes dl-α-tocopheryl acetate or...
|
|
|
7014864 |
Formulations comprising lipid-regulating agents
The present invention is directed to a formulation comprising a lipid-regulating agent dissolved in at least one structured lipid as the primary solvent medium for said agent. One or more...
|
|
|
7012092 |
Formulation and delivery method to enhance antioxidant potency of Vitamin E
A formulation to deliver a full-spectrum of Vitamin E isomers for improved antioxidant capacity, bioavailability, dissolution and efficacy. The formulation includes dl-α-tocopheryl acetate or...
|
|
|
6979456 |
Anticancer compositions
Pharmaceutical dosage forms for anticancer drugs, and paclitaxel in particular, are described in which the active drug is formulated as storage stable self-emulsifying preconcentrate.
|
|
|
6967020 |
Oxygen carrier system, artificial oxygen carrier, and reducing agent
An oxygen carrier system includes an artificial oxygen carrier including hemoglobin vesicles encapsulating hemoglobin and an intermediate electron mediator having a standard electrode potential of...
|